Ray Therapeutics
San Francisco, US · Founded 2021 · Delaware corporation · 10 known investors
Find your way into Ray Therapeutics
Sign up to see every warm intro you have to Ray Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ray Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Restoring vision through optogenetics.
Founders & leadership
Ray Therapeutics was founded in 2021 by Paul Bresge.
Board


Investors · 10
How we know: MRL Ventures Fund's portfolio page · funding news · pulse2.com · Not right? Tell us
How we know: funding news · pulse2.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · pulse2.com · Not right? Tell us
How we know: funding news · pulse2.com · Not right? Tell us
How we know: funding news · pulse2.com · Not right? Tell us
How we know: funding news · pulse2.com · Not right? Tell us
Funding
SEC filings, press & company announcements$145M disclosed across 3 rounds · 2021–2026
- $125MSeries BApr 2026 · 5 sources
Janus Henderson Investors (lead), 4BIO Capital, Adage Capital Management, Deerfield Management, Franklin Templeton, Invus, Marshall Wace, MRL Ventures Fund, Norwest, Novo Holdings, Platanus
Source ↗
▶$14MraisedMay 2023 · 13 investors · BiotechnologyRule 506(b)
- Tiba AynechiDirector
- Dmitry KuzminDirector
- Sean AinsworthExecutive Officer, Director
- Raymond CamahortDirector
- Hannah ChangDirector
- Gary AbramsDirector
- Paul BresgeExecutive Officer, Director
- Offering amount
- $100M
- Amount sold
- $14M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$6MraisedApr 2022 · 15 investors · BiotechnologyRule 506(b)
- Paul BresgeExecutive Officer, Director
- Gary AbramsDirector
- Dmitry KuzminDirector
- Sean AinsworthExecutive Officer, Director
- Cameron GallagherDirector
- Andrew HowardExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- May 2021
- Incorporated
- Corporation, California, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Ray Therapeutics do?
- Restoring vision through optogenetics.
- Who founded Ray Therapeutics?
- Ray Therapeutics was founded by Paul Bresge in 2021.
- Who are Ray Therapeutics's investors?
- Ray Therapeutics's investors include MRL Ventures Fund, 4BIO Capital, 4Bio Ventures, Deerfield Management Company, Franklin Templeton, Invus, Janus Henderson Investors, Norwest Venture Partners and 2 more.
- How much funding has Ray Therapeutics raised?
- Ray Therapeutics has disclosed $145M raised across 3 rounds.
- Where is Ray Therapeutics headquartered?
- Ray Therapeutics is headquartered in San Francisco, US.